查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
細胞分選機市場：按產品、用途和最終用戶：全球機會分析和產業預測，2023-2032年
市場調查報告書
商品編碼
1365593

細胞分選機市場：按產品、用途和最終用戶：全球機會分析和產業預測，2023-2032年

Cell Sorter Market By Product, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032
出版日期: | 出版商: Allied Market Research | 英文 273 Pages | 商品交期: 2-3個工作天內

價格

「由於細胞分選機的進步，細胞分選機在醫療保健和研究中的採用不斷增加，從2023年到2032年，細胞分選機市場可能會經歷8.6%的顯著成長率」 - 根據Allied Market Research 的最新報告「細胞分選機市場」，細胞分選機市場2022年估值為5億美元，預計2023年至2032年年複合成長率為8.6%，到2032年達到13億美元。

細胞分選是根據物理或生物特性從樣本中分離特定細胞類型的過程。這些特性包括大小、型態、生存力以及細胞內和細胞外蛋白質表現。細胞分選產生可用於多種目的的同質細胞群，包括研究、診斷和治療。

細胞分選儀市場-IMG1

細胞分選機市場的推動要素包括持續的技術進步，例如分選速度的提高、靈敏度和準確性的提高以及適應各種樣本量的能力。這些進步使得細胞分選儀更有效率、更容易使用，並且能夠滿足各種研究要求。此外，癌症、自體免疫疾病和感染疾病等慢性疾病的發生率不斷增加，需要先進的研究工具來了解疾病機制並開發有效的治療方法。細胞分選儀有助於詳細的細胞分析，並有助於發現新的治療標靶和診斷生物標記物，支持市場成長。

細胞生物學研究的不斷進步，例如研究稀有細胞群、闡明疾病機制和探索個人化醫療方法，創造對細胞分選技術的需求並推動市場成長。細胞分選儀可讓研究人員分離特定的細胞類型或亞群以進行進一步分析或實驗。此外，政府、私人組織和資助機構日益增加對生命科學研究的投資，包括細胞生物學和免疫學。此類資金支持包括細胞分選儀在內的先進研究工具的開發和採用，是市場開拓的驅動力。然而，細胞分選儀設備的高成本以及新興國家缺乏熟練專業人員限制了細胞分選儀的採用並抑制了市場成長。

目錄

第1章 簡介

第2章 執行摘要

第3章 市場概況

  • 市場定義和範圍
  • 主要發現
    • 影響要素
    • 主要投資機會
  • 波特五力分析
  • 市場動態
    • 促進因素
      • 細胞分選儀技術不斷進步
      • 政府對研發活動的支持迅速增加
      • 愛滋病毒和患病的盛行率不斷上升
    • 抑制因素
      • 細胞分選儀高成本
    • 機會
      • 新興市場的成長機會

第4章 細胞分選機市場：依產品

  • 概述
  • 設備類型
    • 設備類型細胞分選機市場：依類型
  • 消耗品/試劑

第5章 細胞分選機市場：依用途

  • 概述
  • 供研究用途
    • 研究用途細胞分選機市場：依類型
  • 供臨床用途

第6章 細胞分選機市場：依最終用戶分類

  • 概述
  • 醫院和臨床實驗室
  • 製藥和生物技術公司
  • 其他

第7章 細胞分選機市場 細胞分選機市場：依地區

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 澳洲
    • 印度
    • 韓國
    • 其他
  • 拉丁美洲、中東、非洲
    • 巴西
    • 沙烏地阿拉伯
    • 南非
    • 其他

第8章 競爭形勢

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭儀表板
  • 競爭熱圖
  • 2022年主要企業定位

第9章 公司簡介

  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Cytonome/St, LLC
  • Danaher Corporation
  • Harvard Bioscience, Inc.
  • Miltenyi Biotec GmbH
  • On-Chip Biotechnologies Co., Ltd.
  • Thermo Fisher Scientific Inc.
  • Sony Corporation
  • Sysmex Corporation
Product Code: A03964

"The Cell Sorter Market is likely to experience a significant growth rate of 8.6% from 2023-2032 owing to advancement in cell sorters and rise in adoption of cell sorters in healthcare and research" - Allied Market Research. According to a new report published by Allied Market Research, titled, "Cell Sorter Market," The cell sorter market was valued at $0.5 billion in 2022, and is estimated to reach $1.3 billion by 2032, growing at a CAGR of 8.6% from 2023 to 2032. Cell sorting is a procedure that involves the separation of a specific cell type from a sample on the basis of its physical or biological characteristics. These characteristics may include size, morphology, viability, and the expression of proteins both inside and outside the cell. By performing cell sorting, a homogeneous population of cells is obtained, which are utilized for various purposes such as research, diagnosis, and therapy.

Cell Sorter Market - IMG1

The cell sorter market is driven by factors that include continuous technological advancements, such as improvements in sorting speed, increased sensitivity & accuracy, and the ability to handle a wide range of sample volumes. These advancements make cell sorters more efficient, user-friendly, and capable of handling diverse research requirements. In addition, the rise in incidence of chronic diseases, such as cancer, autoimmune disorders, and infectious diseases, creates a need for advanced research tools to understand disease mechanisms and develop effective treatments. Cell sorters facilitate in-depth cellular analysis, aiding in the discovery of novel therapeutic targets and diagnostic biomarkers, which support market growth.

The continuous advancements in cell biology research, such as studying rare cell population, understanding disease mechanisms, and exploring personalized medicine approaches, create a demand for cell sorting technologies and propels market growth. Cell sorters enable researchers to isolate specific cell types or subpopulation for further analysis and experimentation. Moreover, governments, private organizations, and funding agencies are increasingly investing in life sciences research, including cell biology and immunology. This funding supports the development and adoption of advanced research tools, including cell sorters, and drives market growth. However, the high cost of cell sorter instruments and lack of skilled professionals in developing countries limit the adoption of cell sorter and restrain market growth.

The cell sorter market is segmented into product, application, end user, and region. By product, the market is segregated into instruments and consumables & reagents. The instrument segment is further categorized into fluorescence-based droplet cell sorting, magnetic-activated cell sorting, and MEMS- Microfluidics. By application, the market is bifurcated into research applications and clinical applications. The research applications segment is further categorized into immunology & cancer research, stem cell research, drug discovery, and other research applications. By end user, the market is categorized into hospitals & clinical testing laboratories, pharmaceutical & biotechnology companies, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and Rest of LAMEA).

Major key players that operate in the cell sorter market are Becton, Dickinson and Company, Bio-Rad Laboratories, Inc. Cytonome/St, LLC, Danaher Corporation, Harvard Bioscience, Inc., Miltenyi Biotec GmbH, On-Chip Biotechnologies Co., Ltd., Sony Corporation, Sysmex Corporation, and Thermo Fisher Scientific Inc. Key players have adopted product launch, partnership, and acquisition as key developmental strategies to improve the product portfolio of the cell sorter market.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cell sorter market analysis from 2022 to 2032 to identify the prevailing cell sorter market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the cell sorter market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global cell sorter market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 20% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Criss-cross segment analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Product

  • Instruments
    • Type
    • Fluorescence-based Droplet Cell Sorting
    • Magnetic-activated Cell Sorting
    • MEMS - Microfluidics
  • Consumables and Reagents

By Application

  • Research Application
    • Type
    • Immunology and Cancer Research
    • Stem Cell Research
    • Drug Discovery
    • Other Research Applications
  • Clinical Applications

By End User

  • Hospitals and Clinical Testing Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Becton, Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • Cytonome/St, LLC
    • Danaher Corporation
    • Harvard Bioscience, Inc.
    • Miltenyi Biotec GmbH
    • On-Chip Biotechnologies Co., Ltd.
    • Sony Corporation
    • Sysmex Corporation
    • Thermo Fisher Scientific Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Moderate bargaining power of suppliers
    • 3.3.2. Moderate threat of new entrants
    • 3.3.3. Low threat of substitutes
    • 3.3.4. Moderate intensity of rivalry
    • 3.3.5. Low bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Rise in technological advancements in cell sorters
      • 3.4.1.2. Surge in government support for R&D activities
      • 3.4.1.3. Increase in prevalence of HIV and cancer
    • 3.4.2. Restraints
      • 3.4.2.1. High cost of cell sorters
    • 3.4.3. Opportunities
      • 3.4.3.1. Growth opportunities in emerging markets

CHAPTER 4: CELL SORTER MARKET, BY PRODUCT

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Instruments
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
    • 4.2.4. Instruments Cell Sorter Market by Type
  • 4.3. Consumables and Reagents
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country

CHAPTER 5: CELL SORTER MARKET, BY APPLICATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Research Application
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
    • 5.2.4. Research Application Cell Sorter Market by Type
  • 5.3. Clinical Applications
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country

CHAPTER 6: CELL SORTER MARKET, BY END USER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Hospitals and Clinical Testing Laboratories
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Pharmaceutical and Biotechnology Companies
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Others
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: CELL SORTER MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by Product
    • 7.2.3. Market size and forecast, by Application
    • 7.2.4. Market size and forecast, by End User
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Market size and forecast, by Product
      • 7.2.5.1.2. Market size and forecast, by Application
      • 7.2.5.1.3. Market size and forecast, by End User
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Market size and forecast, by Product
      • 7.2.5.2.2. Market size and forecast, by Application
      • 7.2.5.2.3. Market size and forecast, by End User
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Market size and forecast, by Product
      • 7.2.5.3.2. Market size and forecast, by Application
      • 7.2.5.3.3. Market size and forecast, by End User
  • 7.3. Europe
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by Product
    • 7.3.3. Market size and forecast, by Application
    • 7.3.4. Market size and forecast, by End User
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Market size and forecast, by Product
      • 7.3.5.1.2. Market size and forecast, by Application
      • 7.3.5.1.3. Market size and forecast, by End User
      • 7.3.5.2. France
      • 7.3.5.2.1. Market size and forecast, by Product
      • 7.3.5.2.2. Market size and forecast, by Application
      • 7.3.5.2.3. Market size and forecast, by End User
      • 7.3.5.3. UK
      • 7.3.5.3.1. Market size and forecast, by Product
      • 7.3.5.3.2. Market size and forecast, by Application
      • 7.3.5.3.3. Market size and forecast, by End User
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Market size and forecast, by Product
      • 7.3.5.4.2. Market size and forecast, by Application
      • 7.3.5.4.3. Market size and forecast, by End User
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Market size and forecast, by Product
      • 7.3.5.5.2. Market size and forecast, by Application
      • 7.3.5.5.3. Market size and forecast, by End User
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Market size and forecast, by Product
      • 7.3.5.6.2. Market size and forecast, by Application
      • 7.3.5.6.3. Market size and forecast, by End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by Product
    • 7.4.3. Market size and forecast, by Application
    • 7.4.4. Market size and forecast, by End User
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Market size and forecast, by Product
      • 7.4.5.1.2. Market size and forecast, by Application
      • 7.4.5.1.3. Market size and forecast, by End User
      • 7.4.5.2. China
      • 7.4.5.2.1. Market size and forecast, by Product
      • 7.4.5.2.2. Market size and forecast, by Application
      • 7.4.5.2.3. Market size and forecast, by End User
      • 7.4.5.3. Australia
      • 7.4.5.3.1. Market size and forecast, by Product
      • 7.4.5.3.2. Market size and forecast, by Application
      • 7.4.5.3.3. Market size and forecast, by End User
      • 7.4.5.4. India
      • 7.4.5.4.1. Market size and forecast, by Product
      • 7.4.5.4.2. Market size and forecast, by Application
      • 7.4.5.4.3. Market size and forecast, by End User
      • 7.4.5.5. South Korea
      • 7.4.5.5.1. Market size and forecast, by Product
      • 7.4.5.5.2. Market size and forecast, by Application
      • 7.4.5.5.3. Market size and forecast, by End User
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Market size and forecast, by Product
      • 7.4.5.6.2. Market size and forecast, by Application
      • 7.4.5.6.3. Market size and forecast, by End User
  • 7.5. LAMEA
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by Product
    • 7.5.3. Market size and forecast, by Application
    • 7.5.4. Market size and forecast, by End User
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Market size and forecast, by Product
      • 7.5.5.1.2. Market size and forecast, by Application
      • 7.5.5.1.3. Market size and forecast, by End User
      • 7.5.5.2. Saudi Arabia
      • 7.5.5.2.1. Market size and forecast, by Product
      • 7.5.5.2.2. Market size and forecast, by Application
      • 7.5.5.2.3. Market size and forecast, by End User
      • 7.5.5.3. South Africa
      • 7.5.5.3.1. Market size and forecast, by Product
      • 7.5.5.3.2. Market size and forecast, by Application
      • 7.5.5.3.3. Market size and forecast, by End User
      • 7.5.5.4. Rest of LAMEA
      • 7.5.5.4.1. Market size and forecast, by Product
      • 7.5.5.4.2. Market size and forecast, by Application
      • 7.5.5.4.3. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

  • 9.1. Becton, Dickinson and Company
    • 9.1.1. Company overview
    • 9.1.2. Key Executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. Business performance
    • 9.1.7. Key strategic moves and developments
  • 9.2. Bio-Rad Laboratories, Inc.
    • 9.2.1. Company overview
    • 9.2.2. Key Executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
    • 9.2.6. Business performance
    • 9.2.7. Key strategic moves and developments
  • 9.3. Cytonome/St, LLC
    • 9.3.1. Company overview
    • 9.3.2. Key Executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
  • 9.4. Danaher Corporation
    • 9.4.1. Company overview
    • 9.4.2. Key Executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
    • 9.4.6. Business performance
  • 9.5. Harvard Bioscience, Inc.
    • 9.5.1. Company overview
    • 9.5.2. Key Executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
    • 9.5.6. Business performance
  • 9.6. Miltenyi Biotec GmbH
    • 9.6.1. Company overview
    • 9.6.2. Key Executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
  • 9.7. On-Chip Biotechnologies Co., Ltd.
    • 9.7.1. Company overview
    • 9.7.2. Key Executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
    • 9.7.6. Key strategic moves and developments
  • 9.8. Thermo Fisher Scientific Inc.
    • 9.8.1. Company overview
    • 9.8.2. Key Executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
    • 9.8.6. Business performance
    • 9.8.7. Key strategic moves and developments
  • 9.9. Sony Corporation
    • 9.9.1. Company overview
    • 9.9.2. Key Executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
    • 9.9.6. Business performance
  • 9.10. Sysmex Corporation
    • 9.10.1. Company overview
    • 9.10.2. Key Executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio
    • 9.10.6. Business performance

LIST OF TABLES

  • TABLE 01. GLOBAL CELL SORTER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 02. CELL SORTER MARKET FOR INSTRUMENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. GLOBAL INSTRUMENTS CELL SORTER MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 04. CELL SORTER MARKET FOR CONSUMABLES AND REAGENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 05. GLOBAL CELL SORTER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 06. CELL SORTER MARKET FOR RESEARCH APPLICATION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 07. GLOBAL RESEARCH APPLICATION CELL SORTER MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 08. CELL SORTER MARKET FOR CLINICAL APPLICATIONS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 09. GLOBAL CELL SORTER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 10. CELL SORTER MARKET FOR HOSPITALS AND CLINICAL TESTING LABORATORIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. CELL SORTER MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. CELL SORTER MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. CELL SORTER MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. NORTH AMERICA CELL SORTER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 15. NORTH AMERICA CELL SORTER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 16. NORTH AMERICA CELL SORTER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 17. NORTH AMERICA CELL SORTER MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 18. U.S. CELL SORTER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 19. U.S. CELL SORTER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 20. U.S. CELL SORTER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 21. CANADA CELL SORTER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 22. CANADA CELL SORTER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 23. CANADA CELL SORTER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 24. MEXICO CELL SORTER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 25. MEXICO CELL SORTER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 26. MEXICO CELL SORTER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 27. EUROPE CELL SORTER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 28. EUROPE CELL SORTER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 29. EUROPE CELL SORTER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 30. EUROPE CELL SORTER MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 31. GERMANY CELL SORTER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 32. GERMANY CELL SORTER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 33. GERMANY CELL SORTER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 34. FRANCE CELL SORTER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 35. FRANCE CELL SORTER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 36. FRANCE CELL SORTER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 37. UK CELL SORTER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 38. UK CELL SORTER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 39. UK CELL SORTER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 40. ITALY CELL SORTER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 41. ITALY CELL SORTER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 42. ITALY CELL SORTER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 43. SPAIN CELL SORTER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 44. SPAIN CELL SORTER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 45. SPAIN CELL SORTER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 46. REST OF EUROPE CELL SORTER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 47. REST OF EUROPE CELL SORTER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 48. REST OF EUROPE CELL SORTER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 49. ASIA-PACIFIC CELL SORTER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 50. ASIA-PACIFIC CELL SORTER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 51. ASIA-PACIFIC CELL SORTER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 52. ASIA-PACIFIC CELL SORTER MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 53. JAPAN CELL SORTER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 54. JAPAN CELL SORTER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 55. JAPAN CELL SORTER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 56. CHINA CELL SORTER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 57. CHINA CELL SORTER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 58. CHINA CELL SORTER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 59. AUSTRALIA CELL SORTER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 60. AUSTRALIA CELL SORTER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 61. AUSTRALIA CELL SORTER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 62. INDIA CELL SORTER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 63. INDIA CELL SORTER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 64. INDIA CELL SORTER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 65. SOUTH KOREA CELL SORTER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 66. SOUTH KOREA CELL SORTER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 67. SOUTH KOREA CELL SORTER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 68. REST OF ASIA-PACIFIC CELL SORTER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 69. REST OF ASIA-PACIFIC CELL SORTER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 70. REST OF ASIA-PACIFIC CELL SORTER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 71. LAMEA CELL SORTER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 72. LAMEA CELL SORTER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 73. LAMEA CELL SORTER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 74. LAMEA CELL SORTER MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 75. BRAZIL CELL SORTER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 76. BRAZIL CELL SORTER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 77. BRAZIL CELL SORTER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 78. SAUDI ARABIA CELL SORTER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 79. SAUDI ARABIA CELL SORTER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 80. SAUDI ARABIA CELL SORTER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 81. SOUTH AFRICA CELL SORTER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 82. SOUTH AFRICA CELL SORTER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 83. SOUTH AFRICA CELL SORTER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 84. REST OF LAMEA CELL SORTER MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 85. REST OF LAMEA CELL SORTER MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 86. REST OF LAMEA CELL SORTER MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 87. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
  • TABLE 88. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • TABLE 89. BECTON, DICKINSON AND COMPANY: PRODUCT SEGMENTS
  • TABLE 90. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
  • TABLE 91. BECTON, DICKINSON AND COMPANY: KEY STRATERGIES
  • TABLE 92. BIO-RAD LABORATORIES, INC.: KEY EXECUTIVES
  • TABLE 93. BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
  • TABLE 94. BIO-RAD LABORATORIES, INC.: PRODUCT SEGMENTS
  • TABLE 95. BIO-RAD LABORATORIES, INC.: PRODUCT PORTFOLIO
  • TABLE 96. BIO-RAD LABORATORIES, INC.: KEY STRATERGIES
  • TABLE 97. CYTONOME/ST, LLC: KEY EXECUTIVES
  • TABLE 98. CYTONOME/ST, LLC: COMPANY SNAPSHOT
  • TABLE 99. CYTONOME/ST, LLC: PRODUCT SEGMENTS
  • TABLE 100. CYTONOME/ST, LLC: PRODUCT PORTFOLIO
  • TABLE 101. DANAHER CORPORATION: KEY EXECUTIVES
  • TABLE 102. DANAHER CORPORATION: COMPANY SNAPSHOT
  • TABLE 103. DANAHER CORPORATION: PRODUCT SEGMENTS
  • TABLE 104. DANAHER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 105. HARVARD BIOSCIENCE, INC.: KEY EXECUTIVES
  • TABLE 106. HARVARD BIOSCIENCE, INC.: COMPANY SNAPSHOT
  • TABLE 107. HARVARD BIOSCIENCE, INC.: PRODUCT SEGMENTS
  • TABLE 108. HARVARD BIOSCIENCE, INC.: PRODUCT PORTFOLIO
  • TABLE 109. MILTENYI BIOTEC GMBH: KEY EXECUTIVES
  • TABLE 110. MILTENYI BIOTEC GMBH: COMPANY SNAPSHOT
  • TABLE 111. MILTENYI BIOTEC GMBH: PRODUCT SEGMENTS
  • TABLE 112. MILTENYI BIOTEC GMBH: PRODUCT PORTFOLIO
  • TABLE 113. ON-CHIP BIOTECHNOLOGIES CO., LTD.: KEY EXECUTIVES
  • TABLE 114. ON-CHIP BIOTECHNOLOGIES CO., LTD.: COMPANY SNAPSHOT
  • TABLE 115. ON-CHIP BIOTECHNOLOGIES CO., LTD.: PRODUCT SEGMENTS
  • TABLE 116. ON-CHIP BIOTECHNOLOGIES CO., LTD.: PRODUCT PORTFOLIO
  • TABLE 117. ON-CHIP BIOTECHNOLOGIES CO., LTD.: KEY STRATERGIES
  • TABLE 118. THERMO FISHER SCIENTIFIC INC.: KEY EXECUTIVES
  • TABLE 119. THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
  • TABLE 120. THERMO FISHER SCIENTIFIC INC.: PRODUCT SEGMENTS
  • TABLE 121. THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
  • TABLE 122. THERMO FISHER SCIENTIFIC INC.: KEY STRATERGIES
  • TABLE 123. SONY CORPORATION: KEY EXECUTIVES
  • TABLE 124. SONY CORPORATION: COMPANY SNAPSHOT
  • TABLE 125. SONY CORPORATION: SERVICE SEGMENTS
  • TABLE 126. SONY CORPORATION: PRODUCT PORTFOLIO
  • TABLE 127. SYSMEX CORPORATION: KEY EXECUTIVES
  • TABLE 128. SYSMEX CORPORATION: COMPANY SNAPSHOT
  • TABLE 129. SYSMEX CORPORATION: PRODUCT SEGMENTS
  • TABLE 130. SYSMEX CORPORATION: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. CELL SORTER MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF CELL SORTER MARKET,2022-2032
  • FIGURE 03. TOP INVESTMENT POCKETS IN CELL SORTER MARKET (2023-2032)
  • FIGURE 04. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 05. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 06. LOW THREAT OF SUBSTITUTES
  • FIGURE 07. MODERATE INTENSITY OF RIVALRY
  • FIGURE 08. LOW BARGAINING POWER OF BUYERS
  • FIGURE 09. GLOBAL CELL SORTER MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 10. CELL SORTER MARKET, BY PRODUCT, 2022 AND 2032(%)
  • FIGURE 11. COMPARATIVE SHARE ANALYSIS OF CELL SORTER MARKET FOR INSTRUMENTS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF CELL SORTER MARKET FOR CONSUMABLES AND REAGENTS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 13. CELL SORTER MARKET, BY APPLICATION, 2022 AND 2032(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF CELL SORTER MARKET FOR RESEARCH APPLICATION, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF CELL SORTER MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 16. CELL SORTER MARKET, BY END USER, 2022 AND 2032(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF CELL SORTER MARKET FOR HOSPITALS AND CLINICAL TESTING LABORATORIES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF CELL SORTER MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF CELL SORTER MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 20. CELL SORTER MARKET BY REGION, 2022 AND 2032(%)
  • FIGURE 21. U.S. CELL SORTER MARKET, 2022-2032 ($MILLION)
  • FIGURE 22. CANADA CELL SORTER MARKET, 2022-2032 ($MILLION)
  • FIGURE 23. MEXICO CELL SORTER MARKET, 2022-2032 ($MILLION)
  • FIGURE 24. GERMANY CELL SORTER MARKET, 2022-2032 ($MILLION)
  • FIGURE 25. FRANCE CELL SORTER MARKET, 2022-2032 ($MILLION)
  • FIGURE 26. UK CELL SORTER MARKET, 2022-2032 ($MILLION)
  • FIGURE 27. ITALY CELL SORTER MARKET, 2022-2032 ($MILLION)
  • FIGURE 28. SPAIN CELL SORTER MARKET, 2022-2032 ($MILLION)
  • FIGURE 29. REST OF EUROPE CELL SORTER MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. JAPAN CELL SORTER MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. CHINA CELL SORTER MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. AUSTRALIA CELL SORTER MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. INDIA CELL SORTER MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. SOUTH KOREA CELL SORTER MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. REST OF ASIA-PACIFIC CELL SORTER MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. BRAZIL CELL SORTER MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. SAUDI ARABIA CELL SORTER MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. SOUTH AFRICA CELL SORTER MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. REST OF LAMEA CELL SORTER MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. TOP WINNING STRATEGIES, BY YEAR (2020-2023)
  • FIGURE 41. TOP WINNING STRATEGIES, BY DEVELOPMENT (2020-2023)
  • FIGURE 42. TOP WINNING STRATEGIES, BY COMPANY (2020-2023)
  • FIGURE 43. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 44. COMPETITIVE DASHBOARD
  • FIGURE 45. COMPETITIVE HEATMAP: CELL SORTER MARKET
  • FIGURE 46. TOP PLAYER POSITIONING, 2022
  • FIGURE 47. BECTON, DICKINSON AND COMPANY: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 48. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 49. BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 50. BIO-RAD LABORATORIES, INC.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 51. BIO-RAD LABORATORIES, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 52. BIO-RAD LABORATORIES, INC.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 53. DANAHER CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 54. DANAHER CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 55. DANAHER CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 56. HARVARD BIOSCIENCE, INC.: NET REVENUE, 2018-2020 ($MILLION)
  • FIGURE 57. HARVARD BIOSCIENCE, INC.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 58. THERMO FISHER SCIENTIFIC, INC.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 59. THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 60. THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 61. SONY CORPORATION: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 62. SONY CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 63. SONY CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 64. SYSMEX CORPORATION: NET REVENUE, 2021-2023 ($MILLION)
  • FIGURE 65. SYSMEX CORPORATION: REVENUE SHARE BY REGION, 2023 (%)